P
PRPO
Precipio Inc
27.90
-0.60-2.11%After Hours: 27.35 -0.55 -1.97%18:10 04/08 EDT
OPEN/PREV CLOSE28.84/28.50
TODAY RANGE26.86-28.84
VOL13.05K
MARKET CAP49.76M
52 WEEK RANGE3.900-29.53
AVG VOL (3M)21.23K
% TURNOVER0.73%
TURNOVER--
P/E (TTM)-123.3422
% RANGE6.95%
EPS(TTM)-0.2262
P/E(FORWARD)1.701
P/B3.412
BVPS8.18
DIVIDEND--
P/S2.066
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP43.85M
SHARES OUTSTANDING1.78M
NEXT EARNINGS05/12-05/18
FREE FLOAT1.57M
LOT SIZE1
EX-DATE09/22/2023
News
Press Releases
Financial Reports
Profile
TipRanks·44m ago
Precipio Earnings Call Signals Profitable Growth Pivot
Seeking Alpha·2d ago
Precipio GAAP EPS of -$0.23, revenue of $24.05M
Seeking Alpha·6d ago
Here are the major earnings after the close Thursday
Benzinga·6d ago
Earnings Scheduled For April 2, 2026
Reuters·03/30 21:41
Precipio FY25 net sales climb 30% to $24M; operating loss narrows to $1.2M
Seeking Alpha·03/29 12:07
Earnings week ahead: NKE, TLRY, SPCE, BYND, NNDM, CAG, and more
Reuters·03/12 21:00
Precipio Inc. to Host Q4 and Year-End 2025 Shareholder Update Call
TipRanks·03/10 13:05
Precipio announces publication in Journal of Clinical Pathology
Reuters·02/25 14:44
Blood cancer diagnostics firm Precipio's prelim Q4 revenue rises 23%
Dow Jones·02/25 14:38
*Precipio 4Q Rev $6.7M >PRPO
Dow Jones·02/25 14:38
*Precipio 4Q Net $500,000 >PRPO
TipRanks·02/25 14:36
Precipio reports FY25 revenue $24M vs. $18.5M last year
Benzinga·02/25 14:33
Precipio Q4 2025 Preliminary Revenue $6.7M, An Increase Of 23% From $5.4M YoY
TipRanks·01/15 14:11
Precipio announces steps towards clean balance sheet
Same Industry
Name/Symbol
Change%
Price